|
|
|
|
|
|
|
|
Four therapeutic areas
Solvay Pharmaceuticals’ research and development is focused on four therapeutic areas:
(two key focus areas and two specific medical need areas)
-
cardio-metabolic:Dyslipidemias, Type 2 Diabetes, Acute Heart Failure, Diabetic Nephropathy, Pulmonary hypertension, Atherosclerosis
-
neuroscience: Psychosis, Bipolar Disorder, Parkinson’s Disease, Traumatic Brain Injury, Exploratory platforms
-
influenza vaccines : Bioengineered Enzymes
-
pancreatic enzymes: New delivery systems, Adjuvants
In 2008, Research & Development costs amounted to EUR 428 million (16% of sales)
|
|
|
|
|
|
|
|
